Phase III trial of consolidation therapy with yttrium-90-ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma.

Translated title of the contribution: Phase III trial of consolidation therapy with yttrium-90-ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma.

F. Morschhauser, J. Radford, A. van Hoof, U. Vitolo, P. Soubeyran, H. Tilly, P.C. Huijgens, A. Kolstad, F. D'Amore, M. Gonsalez Diaz, M. Petrini, C. Sebban, P.L. Zinzani, M.H.J. van Oers, W. van Putten, A. Bischof-Delaloye, A. Rohatiner, G. Salles, J. Kuhlmann, A. Hagenbeek

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionPhase III trial of consolidation therapy with yttrium-90-ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma.
Original languageUndefined/Unknown
Pages (from-to)5156-5164
Number of pages9
JournalJournal of Clinical Oncology
Volume26
Issue number32
Publication statusPublished - 2008

Cite this